GRPR and neoplasm: After administration of the tracer (25–50 μg peptide/dose) several pathological lesions including lymph nodes, liver and bone metastasis were visualized and [68Ga]Ga-AMBA proved to be a valuable tool to assess GRPR tumor expression status.